-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Pharmagreen Biotech Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2018 to Q2 2023.
- Pharmagreen Biotech Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$163K, a 165% decline year-over-year.
- Pharmagreen Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$876K, a 80.7% increase from 2021.
- Pharmagreen Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$4.53M, a 82.6% decline from 2020.
- Pharmagreen Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$2.48M, a 223% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)